drugset / Trial / NCT06703840

Phase 2a Trial to Investigate the Efficacy of LIB-01 in Treatment of Erectile Dysfunction

NCT06703840 ↗

Phase 2 Completed 156 enrolled Dicot AB
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this clinical trial is to learn if the drug LIB-01 works to treat erectile dysfunction in male adults. It will also learn about the safety of the drug LIB-01. The main questions it aims to answer are: * Does the drug LIB-01 improve erectile function in males with erectile dysfunction? * What medical problems do participants have when taking the drug LIB-01? Researchers will compare the drug LIB-01 to a placebo (a look-alike substance that contains no drug) to see if the drug LIB-01 works to treat erectile dysfunction. Participants will: * Take the drug LIB-01 or a placebo every day for 3 days * Visit the clinic every week for 4 weeks, and at 8 weeks, for checkups and tests

Timeline

Start
2024-11-08
Primary completion
2025-07-19
Completion
2025-08-19

Drugs

EvaluationDrugModalityDoseRoute
Subject LIB-01 Unknown 10 mg Oral
Subject LIB-01 Unknown 25 mg Oral
Subject LIB-01 Unknown 50 mg Oral

Indications